FDANews
www.fdanews.com/articles/190589-fda-allows-marketing-of-device-for-carbon-monoxide-treatment
FDA_Logo_Blue_2016.gif

FDA Allows Marketing of Device for Carbon Monoxide Treatment

March 15, 2019

The FDA has given the green light for Thornhill Medical’s ClearMate, a device for use in emergency rooms for treating patients with carbon monoxide poisoning.

The mask device — which is made up of valves, meters, breathing circuits, a gas mixer and an oxygen reservoir — can quickly remove carbon monoxide from the body by increasing the patient’s rate of breathing.

ClearMate provides pure oxygen to the patient and a mixture of carbon dioxide and oxygen, making the patient breathe faster to speed up the rate of carbon dioxide exiting the body.

View today's stories